Susquehanna International Group’s AC Immune ACIU Stock Holding History
Bought
Maintained
Sold
Other funds holding ACIU
BI
Susquehanna International Group's ACIU Position: Q1 2026 in Review
Susquehanna International Group reduced its AC Immune (ACIU) stake by 40% in Q1 2026, selling an estimated $181K and leaving 89,262 shares worth $245K. The position accounts for ﹤0.01% of the portfolio, ranked #11303.
Susquehanna International Group first reported a position in ACIU in Q2 2020 and has held it in 14 quarters since. The position peaked at $686K in Q4 2020. 46 funds tracked by Wall St. Rank hold ACIU as of Q1 2026.
- Susquehanna International Group held 89,262 shares of AC Immune worth $245K as of Q1 2026.
- Susquehanna International Group sold 58,363 AC Immune shares in Q1 2026, an estimated $181K.
- AC Immune made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #11303 holding.
- Susquehanna International Group first reported a position in AC Immune in Q2 2020 and has held it in 14 quarters since.
- Susquehanna International Group's AC Immune position peaked at $686K in Q4 2020.
- 46 funds tracked by Wall St. Rank held AC Immune as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.